RxDoctor Payments Data
★ My doctorsLook up a doctor →

Rohan Clarke, MD

Gastroenterology · Fort Worth, TXNPI 1336364041

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.5% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 41.1% of the total. 2025 is the largest year on record at $1,648, 3.0 times the $546 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.

$3,511in general payments, 2019–2025

Across 141 payments — averaging $24.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$303
  • Gilead$229
  • Boston Scientific$213
  • Bristol Myers Squibb$173
  • Takeda Pharmaceuticals U.S.A., Inc.$140
  • plus $1K from 17 others

What the payments were for

  • Grants$33510%
  • Food & beverage$3,17690%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie62$1,444
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$303
Gilead9$229
Boston Scientific2$213
Bristol Myers Squibb9$173
Takeda Pharmaceuticals U.S.A., Inc.6$140
QOL Medical, LLC8$139
Covidien LP1$113
Janssen Scientific Affairs, LLC1$95
Sanofi3$90
Regeneron Healthcare Solutions, Inc.4$87
Pfizer4$78
Johnson & Johnson4$74
Merck3$61
Phathom Pharmaceuticals, Inc.3$57
Ardelyx, Inc.2$44
Lilly USA, LLC2$40
Intercept Pharmaceuticals, Inc.2$39
Biocon Biologics Inc1$21
Mirum Pharmaceuticals, Inc.1$19
Boehringer Ingelheim1$18
Novo Nordisk1$17
Aimmune Therapeutics, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,511 in reported general payments places this provider in the 50th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Medicare billing

Part B allowed, 2024
$64,776
Medicare patients
203
Services billed
511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl161$2,613
Pantoprazole Sodium94$625
Omeprazole17$309
Lactulose31$263
Dicyclomine Hcl11$165
Famotidine17$118

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Fort Worth

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →